insights_auto
Waarom is REGN34 gestegen 2,55%?
Meer informatiechevron_right
REGN34:BVMF
Regeneron Pharmaceuticals
R$ 65,04
arrow_upward
+2,55%(+1,62) 1D
14 okt, 16:56:00 GMT-3 · BRL
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor REGN34 genereren…
Openen
R$ 64,20
Hoog
R$ 65,04
Laag
R$ 64,20
Beursw.
80,14 mld.
Gem. vol.
781,00
Volume
136,00
52 wk hoog
R$ 73,13
52 wk laag
R$ 49,91
Uitstaande aandelen
101,14 mln.
Aantal medewerkers
15K
Openen
R$ 64,20
Hoog
R$ 65,04
Laag
R$ 64,20
Beursw.
80,14 mld.
Gem. vol.
781,00
Volume
136,00
52 wk hoog
R$ 73,13
52 wk laag
R$ 49,91
Uitstaande aandelen
101,14 mln.
Aantal medewerkers
15K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Investing.com Canada
·
35 minuten geleden
Form 144 REGENERON PHARMACEUTICALS For: 14 October By Investing.com
Investor's Business Daily
·
48 minuten geleden
Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
Stock Titan
·
52 minuten geleden
After acquiring 4,174 shares via stock options, a Regeneron (Nasdaq: REGN) officer proposes a sale.
MarketBeat
·
1 uur geleden
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% - Here's What Happened
Profiel
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Over Regeneron Pharmaceuticals
CEOLeonard Schleifer
Medewerkers15,3K
Opgericht1988
HoofdkantoorTarrytown, New York, Verenigde Staten
Sector-
Websiteregeneron.com